Arcturus Therapeutics Holdings Inc
ARCT
Get informed when a big investor buys or sells
+ FollowMarket Cap$210.61M
Close$
$-5.66
172% downside
Current Fair Value
172% downsideOvervalued by 172% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $210.61 Million |
|---|---|
| Enterprise Value | $48.34 Million |
| Dividend Yield | $0.68 (-) |
| Earnings per Share | $-2.4 |
| Beta | 2.36 |
| Outstanding Shares | 28,423,000 |
Return
| Return on Equity | -37.47% |
|---|---|
| Return on Assets | -28.70% |
| Return on Invested Capital | -51.89% |
Valuation & Multiples
| P/E Ratio | -2.23 |
|---|---|
| PEG | -1.4 |
| Price to Sales | - |
| Price to Book Ratio | 1.31 |
| Enterprise Value to Revenue | 2.63 |
| Enterprise Value to EBIT | -0.49 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.6 |
| Debt to Equity | 0.17 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 10, 2026
EPS Estimate
$-1.07
Average shareholder expectationRevenue Estimate
$3.11 M
Average shareholder expectationNext Earnings Call
Expected Date
November 9, 2026
EPS Estimate
$-0.62
Average shareholder expectationRevenue Estimate
$8.00 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.1188▼ 67.90% |
|---|---|
| Total Calls | 12,621▼ 94.40% |
| Total Puts | 1,500▼ 99.17% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 23.31%▼ 62.15% |
|---|---|
| Total Invested | $44.52M▼ 76.23% |
| Investors Holding | 50▼ 80.00% |
ESG Score
No data